2796 results
management diagnosis clinical algorithm differential table medications comparison cardiology causes neurology antibiotics video physicalexam nephrology syndrome hematology dosing pathophysiology infections
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS Recommendations
Women with in HIV-AIDS ... known to have HIV ... diagnosed with HIV ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir & Cobicistat Ritonavir & Cobicistat are 2 pharmacokinetic boosters used
HIV Antiretroviral ... boosters used in HIV ... treatment to increase ... Ritonavir #Cobicistat #HIV ... #Boosters #Pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... Infections in HIV-AIDS ... • Continue treatment ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
Trypanosomiasis) in HIV-AIDS ... duration same as for treatment ... Disease Note: Treatment ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... 400 mg) PO or IV ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
Encephalitis in HIV-AIDS ... IDSA #Prevention #Treatment ... HIVAIDS #management #pharmacology ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... to 5 mg/kg/day IV ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
Infections in HIV-AIDS ... PO (or 400 mg IV ... PO (or 400 mg IV ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS Indications for Initiating Primary Prophylaxis:
Prevention and Treatment ... Pneumonia (PCP) in HIV-AIDS ... cells/mm3 and HIV ... IDSA #Prevention #Treatment ... HIVAIDS #management #pharmacology
No results found for "HIV pharmacology treatment"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #HIV #pharmacology #treatment